Home › Funds › Palumbo Wealth Management LLC › NPCE
Palumbo Wealth Management LLC position in NPCE
NEUROPACE INC · Health Care
Palumbo Wealth Management LLC reported holding 167,945 shares of NPCE (NEUROPACE INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.48% of its reported portfolio and ranking #41 among its reported holdings. Palumbo Wealth Management LLC has disclosed NPCE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Palumbo Wealth Management LLC's NPCE position evolved
Palumbo Wealth Management LLC first disclosed a stake in NPCE in Q4 2024 at 11,517 shares (US$129K). The position peaked in Q2 2026 at 209,199 shares, worth US$3.3M. Across 8 filings, Palumbo Wealth Management LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 167,945 shares valued at US$2.3M — a reduction of -41,254 shares quarter over quarter.. Notable position changes include a 300% increase in Q1 2025 (shares fell 9% over the following quarter), a 268% increase in Q2 2025 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 11.52K | $128.88K | New |
| Q1 2025 | 46.11K | $566.71K | Add |
| Q2 2025 | 169.89K | $1.89M | Add |
| Q3 2025 | 197.48K | $2.04M | Add |
| Q4 2025 | 214.18K | $3.31M | Add |
| Q1 2026 | 210.47K | $2.77M | Reduce |
| Q2 2026 | 209.20K | $3.32M | Reduce |
| Q3 2026 | 167.94K | $2.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NPCE and 13F data
NPCE (NEUROPACE INC) is a Health Care company. 41 other funds we track also report a position in NPCE — the largest reported positions include Soleus Capital Management, L.P. (US$46.3M), First Light Asset Management, LLC (US$45.5M), HighMark Wealth Management LLC (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NPCE
- Soleus Capital Management, L.P. 2.91M sh · $46.26M · Q2 2026
- First Light Asset Management, LLC 2.86M sh · $45.46M · Q2 2026
- HighMark Wealth Management LLC 163.00K sh · $2.59M · Q2 2026
More on Palumbo Wealth Management LLC
FAQ
How long has Palumbo Wealth Management LLC held NPCE?
Palumbo Wealth Management LLC has disclosed NPCE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Palumbo Wealth Management LLC's current position in NPCE?
As of Q3 2026, Palumbo Wealth Management LLC holds 167.94K shares of NPCE (NEUROPACE INC), valued at $2.31M, representing 0.48% of its reported portfolio and ranking #41.
Has Palumbo Wealth Management LLC been buying or selling NPCE?
In the latest 13F filing (Q3 2026), Palumbo Wealth Management LLC reduced its position in NPCE. The position peaked in Q2 2026 at 209.20K shares.
Which other funds hold NPCE?
Other major institutional holders of NPCE include Soleus Capital Management, L.P., First Light Asset Management, LLC, HighMark Wealth Management LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.